Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.
Through our long-standing mastery of technical and regulatory consultation services, LCS serves all areas of FDA-related activities for the Pharma, Biotech, Biologics, Diagnostic, Device & Allied Health Industries. We serve a diverse base of loyal clients worldwide, from emerging-to-enterprise organizations.
Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
Flex is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets. Flex’s health solutions business focuses on medical device and drug delivery design, development and manufacturing solutions for pharmaceutical and medtech companies. Our approach is supported by FDA-registered and ISO 13485 compliant and ISO 11608-1 accredited facilities, with a world-class single quality system across sites. For more information, visit www.flex.com
Our mission is to accelerate market access for medical technologies by quantifying and demonstrating their value to decision-makers.
We are the #1 company for Value-Based Healthcare strategies and implementation in Europe.
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.eu and connect on Twitter and Facebook.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.eu or follow Zimmer Biomet on LinkedIn at www.linkedin.com/company/zimmer-biomet-emea/ and on Twitter at www.twitter.com/zimmerbiomet.
atrify is the leading provider for product content solutions that enables more than 20,000 users in over 50 countries to share accurate and reliable content with UDI regulatory bodies (e.g. EUDAMED or GUDID) as well as their commercial trading partners and end-users such as doctors, nurses or patients. With dedicated expert services, atrify provides a holistic solution portfolio for transparency, regulatory compliance, and cross-channel trading.
From concept and market authorization to commercialization and product maturity, we use our collective technical and industry knowledge to your advantage, helping to protect and secure the future of your product and business. With more than 500 life sciences and health care lawyers across the globe, we work closely with you and each other to tackle tough issues and difficult-to enter markets – no matter where you are today or want to be tomorrow.
The purpose of MedPhab pilot production line is to accelerate the commercialisation of diagnostic devices and instruments for treatment based on photonics, and to reduce the R&D cost. Based on testing the validation of the pilot production line on three application areas: hospital environment, home care devices and equipment for chemical diagnostics. Such project needs the cooperation of a consortium of excellent research institutes and companies
Werfen is a growing, privately held corporation that was founded in 1966 in Barcelona, Spain.
We are a worldwide leader in in vitro diagnostics (IVD) in the specialties of Hemostasis, Acute Care Diagnostics and Autoimmunity.
At present, we operate directly in nearly 30 countries and in more than 100 territories through distributors. Our R&D and production centers are located in the United States and Europe.
